ChartMaxx Receives '2005 BEST IN KLAS' Award in the Document Management & Imaging CategoryLYNDHURST, N.J., Jan 13, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that its MedPlus healthcare
information technology subsidiary was recognized among healthcare IT
executives, as the number one Document Management and Imaging (DMI) vendor in
the 2005 "Top 20: Year-End Best in KLAS" award ((C) 2005 KLAS Enterprises,
LLC. All rights reserved). MedPlus' ChartMaxx(R), an enterprise-wide
electronic health record solution for hospitals, placed first in this
prestigious study for the third time-previously winning the award in 2002,
2004 and mid-year 2005.
ChartMaxx scored highest in a variety of areas including "worth the
effort," "ease of implementation" and "works as promoted." In addition, 100
percent of respondents indicated they would buy ChartMaxx again. KLAS
rankings are based on interviews with healthcare executives, professionals,
and clinicians at more than 4,500 hospitals and 2,500 clinics nationwide on
more than 500 different products.
KLAS defines DMI vendors as companies that scan, create, archive, workflow
and validate a variety of clinical and non-clinical (administrative/business)
paper and electronic documents. According to KLAS, DMI systems are emerging as
key solutions for hospitals to gain enterprise access to information while
integrating data from disparate systems.
"We are honored to earn first place again in the 2005 "Top 20: Year-End
Best in KLAS" award in the Document Management and Imaging category for our
ChartMaxx product," said Richard Mahoney, President, MedPlus and Vice
President, Healthcare Information Solutions at Quest Diagnostics. "This award
reflects our commitment to transforming the delivery of healthcare services
through electronic health record solutions that reduce costs and improve the
quality and safety of patient care."
The KLAS report includes favorable commentary from healthcare executives
who highlight ChartMaxx's value. "The support we receive is excellent," said a
KLAS survey respondent. "We reach qualified people at MedPlus who resolve our
issues quickly, even extremely complex problems, in a very proficient manner."
About KLAS Enterprises
KLAS, founded in 1996, is the only research firm that specializes in
providing the healthcare information technology (HIT) industry with unbiased,
factual information on HIT vendor performance. KLAS, teamed with thousands of
healthcare executives, CIOs, directors, managers and clinicians, has created a
dynamic database of information on the performance of HIT vendors. The KLAS
database represents the opinions of healthcare executives, managers and
clinicians from more than 4,500 hospitals and 2,500 clinics on more than 500
different products. The information contained within the database is current,
as it is refreshed daily with new performance evaluations and interviews, so
KLAS clients are able to clearly see how a vendor or product is truly
performing. For further information, visit http://www.healthcomputing.com.
How to Obtain a Copy of the Report
If you have questions about the study or if you would like to purchase a
copy, call toll-free at 800-920-4109 or visit http://www.healthcomputing.com.
About ChartMaxx
ChartMaxx is an enterprise-wide electronic health record solution built on
a document management & imaging foundation that enables healthcare
organizations to enhance performance by improving patient care and maximizing
business results through the efficient collection, access and use of clinical,
financial and administrative information. Immediate, concurrent access to
information makes ChartMaxx a key component in efficient management of patient
records. The solution provides the tools hospitals need to accelerate
turnaround time for chart completion, introduce electronic patient
registration, utilize remote coding, automate release of information and
maximize electronic information access across the entire facility. ChartMaxx
has been implemented in more than 100 hospitals and clinics throughout the
United States and Canada. For more information visit http://www.medplus.com.
About MedPlus
MedPlus, the healthcare information technology subsidiary of Quest
Diagnostics, is a leading developer and integrator of clinical connectivity
and healthcare data management solutions that foster better patient care and
improve business performance for healthcare institutions, physicians and
patients. The company's ChartMaxx and Care360 solutions efficiently and
securely collect, store, manage and integrate clinical information within an
organization, enterprise, practice or community. ChartMaxx, the award-winning
electronic patient record solution, has been implemented in more than 100
hospitals and clinics with more than 115,000 clinical and administrative
users. Care360 is a patient-centric physician portal providing a network of
more than 50,000 physicians and their staff with tools to improve patient care
and overall office efficiency. For more information, visit the Company's Web
site at http://www.medplus.com.
About Quest Diagnostics
Quest Diagnostics is the leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its national network of laboratories and patient
service centers, and provides interpretive consultation through its extensive
medical and scientific staff. Quest Diagnostics is a pioneer in developing
innovative new diagnostic tests and advanced information technology solutions
that help improve patient care. Additional company information is available
at: http://www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause actual results and
outcomes to be materially different. Certain of these risks and uncertainties
may include, but are not limited to, competitive environment, changes in
government regulations, changing relationships with customers, payers,
suppliers and strategic partners and other factors described in the Quest
Diagnostics Incorporated 2004 Form 10-K and subsequent filings.
SOURCE Quest Diagnostics
Investors - Laure Park, +1-201-393-5030, or Media - Jennifer Somers, +1-201-729-8386,
both of Quest Diagnostics